• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

TiUnite implant surface still successful 15 years later

Publication
Article
dentalproductsreport.comdentalproductsreport.com-2015-03-01
Issue 3

In 2000, the new millennium brought with it a new dental implant surface. Fifteen years later, Nobel Biocare's TiUnite has built a reputation for success and is one of the most clinically researched implant surfaces in the world. And, after more than 15 million purchases of implants featuring TiUnite, it’s reportedly become one of the most sought after as well.

In 2000, the new millennium brought with it a new dental implant surface. Fifteen years later, Nobel Biocare's TiUnite has built a reputation for success and is one of the most clinically researched implant surfaces in the world. And, after more than 15 million purchases of implants featuring TiUnite, it’s reportedly become one of the most sought after as well.

For decades, the staged Brånemark osseointegration protocol was the norm for dental implant placement. Then, in the 1990s, studies were published showing a one-stage procedure with early or even immediate loading was also a safe option.

This new procedure reduced treatment times and avoided a second surgery – great for the patient. But the impact on the bone-to-implant surface was a challenge. A new surface that could speed up bone apposition was needed. The solution was TiUnite.

Breaking news: DPR's live coverage of IDS 2015

Faster, stronger osseointegration

The TiUnite implant surface was designed to enhance osseointegration, even under the most challenging conditions. It’s created by using anodic oxidation to make a thickened layer of moderately rough titanium oxide. TiUnite’s micropores reportedly result in stronger osseointegration compared with machined surfaces. It has been proven that bone grows into the pores of TiUnite, leading to strong interlocking between the surface and the bone.

Increased survival rates

Since it hit the market 15 years ago, moderately rough surfaces have virtually replaced the original machined surface. The shift to TiUnite from machined implants is said to have shown a clear decrease in early failures, especially in areas with poor bone density.TiUnite also reportedly makes immediate loading possible more frequently and with superior outcomes. As a result, TiUnite now features on all Nobel Biocare’s implant systems. 

Those looking for further support for TiUnite’s efficacy can refer to substantial clinical evidence. In the 15 years since its launch, TiUnite is said to have become of the most frequently used and clinically researched implant surfaces. It has now featured in more than 270 clinical studies looking at 45,000 implants in more than 13,000 patients with up to 12-year follow-up.

To find out more about TiUnite, visit nobelbiocare.com/TiUnite.

Related reading: Nobel Biocare launches new, complete, cement-free posterior solution at IDS 2015
 

Related Videos
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
Mastermind – Episode 35 – Finding Strength in Our Differences
The Uptime Health Story: An Interview with Uptime Health CEO and Co-Founder Jinesh Patel
Mastermind – Episode 34: Proactive Dentistry, Diagnostics, and Early Detection
2024 Dental Products Report Spring Selection Bracket Reveal Video
Process of Care Workflow and Repairing Early Caries with Guided Enamel Remineralization
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
Related Content
© 2024 MJH Life Sciences

All rights reserved.